ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,345,000 | +7481.7% | 1,993,194 | +3888.3% | 0.04% | +414.3% |
| Q1 2019 | $1,218,000 | +1223.9% | 49,976 | +377.3% | 0.01% | – |
| Q4 2016 | $92,000 | +119.0% | 10,471 | +4.4% | 0.00% | – |
| Q4 2015 | $42,000 | -12.5% | 10,029 | -3.9% | 0.00% | – |
| Q3 2015 | $48,000 | -36.0% | 10,434 | 0.0% | 0.00% | – |
| Q2 2015 | $75,000 | -6.2% | 10,434 | -3.4% | 0.00% | – |
| Q1 2015 | $80,000 | +116.2% | 10,802 | +5.0% | 0.00% | – |
| Q3 2014 | $37,000 | -21.3% | 10,287 | 0.0% | 0.00% | – |
| Q2 2014 | $47,000 | -2.1% | 10,287 | 0.0% | 0.00% | – |
| Q1 2014 | $48,000 | -7.7% | 10,287 | 0.0% | 0.00% | – |
| Q4 2013 | $52,000 | – | 10,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |